Developed through systematic structure-activity relationship studies, it was engineered to optimize GH-releasing potency while minimizing effects on cortisol and prolactin secretion, a selectivity profile that distinguishes it from earlier, less refined GHRPs such as GHRP-2 and GHRP-6

Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
doi: 10.7326/0003-4819-142-7-200504050-00011
Ipamorelin stimulates the hypothalamus to release more human growth hormones